
A DNA vaccine tested in mice that cuts the accumulation of both types of toxic proteins associated with Alzheimer's disease could halve cases of dementia, scientists believe. Scientists say that the new findings may pave the way to a clinical trial for a potential dementia jab.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.